SAYZUGA

EUIPO EUIPO 2019 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark SAYZUGA was filed as Word mark on 09/04/2019 at the European Union Intellectual Property Office.
It was registered as a trademark on 03/04/2020. The current status of the mark is "Trademark registered".

Trademark Details Last update: October 2, 2020

Trademark form Word mark
File reference 018119663
Application date September 4, 2019
Publication date November 26, 2019
Entry date March 4, 2020
Expiration date September 4, 2029

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations namely, pharmaceutical preparations for the treatment, diagnosis and/or prevention of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy and ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain; pharmaceutical preparations

Trademark history

Date Document number Area Entry
October 1, 2020 Change Representative, Published

ID: 11018119663